FeesSafety
Pluang+

US midterm results to clarify Bitcoin outlook for short-term investors, says CryptoQuant founder

Market News
03 Nov 2026, 14:18 WIB
Tokenpost
View Source
Neutral
US midterm results to clarify Bitcoin outlook for short-term investors, says CryptoQuant founder

CryptoQuant founder Ki Young Ju stated that the US midterm election results will help short-term investors better assess Bitcoin's near-term outlook by reducing uncertainty. He described the election as the last major uncertainty for 2026, noting that short-term investors dislike uncertainty and will have a clearer view of Bitcoin once results are known. Ju also linked potential bullish momentum in Bitcoin to a recovery in ETF demand after the election uncertainty fades, mentioning that ETF net inflows have been near zero this year while Bitcoin prices remained stable, indicating subdued demand.

The outlook for Bitcoin around the US midterm election is the focus, with CryptoQuant founder Ki Young Ju noting this event as a key uncertainty for 2026. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 03, 2026 19:03 WIB: out of 50 major cryptocurrencies, 12 rose and 37 fell today. Notable movers include BAL (Balancer) up 11.14% at Rp16.297 with a typical hold time of 85 days, EOS (EOS.IO) up 8.13% at Rp12.649 with a typical hold time of 87 days, and CRV (Curve DAO Token) down 5.07% at Rp4.721 with 60% sell order activity and a typical hold time of 62 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
34 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
34 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
34 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App